Dr. Reddy's Laboratories
RDY
A$23.10
Share price
-1.53%
Change (1 day)
6.62%
Change (1 year)
Categories
EPS for Dr. Reddy's Laboratories (RDY)
EPS in 2024 (TTM): A$0.96
According to Dr. Reddy's Laboratories's latest financial reports the company's current EPS (TTM) is A$0.95. an increase over its 2023 EPS that were of A$0.90.
EPS history for Dr. Reddy's Laboratories from 2012 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 | A$0.95 | 5.52% |
| 2023 | A$0.90 | 8.44% |
| 2022 | A$0.83 | 18.05% |
| 2021 | A$0.70 | 33.95% |
| 2020 | A$0.52 | 21.84% |
| 2019 | A$0.43 | -7.43% |
| 2018 | A$0.47 | 64.4% |
| 2017 | A$0.28 | 7.47% |
| 2016 | A$0.26 | -61.2% |
| 2015 | A$0.68 | 6.04% |
| 2014 | A$0.64 | -5.55% |
| 2013 | A$0.68 | 37.03% |
| 2012 | A$0.49 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | A$2.13 | 123.68% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | A-$1.74 | -283.45% | 🇮🇱 Israel |
 GlaxoSmithKline GSK | A$2.39 | 151.01% | 🇬🇧 UK |
 Novartis NVS | A$9.84 | 934.73% | 🇨🇭 Switzerland |
 Sanofi SNY | A$4.36 | 358.17% | 🇫🇷 France |